Evidence map›Paper›PMID 42370321›Full record

ArticleMolecular imaging

Carrier-Free Ce6&SR717 Nanomedicine Enables Abscopal Photoimmunotherapy via cGAS-STING Activation in Breast Cancer.

Xin Peng, Yi Sun, Yudong Guan, Tong Su, Xu Yang, Yanqiu Zhang, Youzhi Qi, Xiaoli Mai, Xuzhi Shi, Yongkang Dai and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xin PengDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.ORCID 0009-0005-4449-8845
Yi SunDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Yudong GuanSchool of Stomatology, Zhongzhou Laboratory, Henan University, Kaifeng, Henan, China.
Tong SuDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Xu YangDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Yanqiu ZhangDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Youzhi QiDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Xiaoli MaiDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Xuzhi ShiKey Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing University of Posts & Telecommunications, Nanjing, PR China.
Yongkang DaiSchool of Stomatology, Zhongzhou Laboratory, Henan University, Kaifeng, Henan, China.
Guang LiDepartment of Gynecological Oncology and Cervical Lesions, NHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospital), Changsha, China.
Yunmeng BaiSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.ORCID 0000-0001-7915-4501
Pu ZhangDepartment of Gynecological Oncology and Cervical Lesions, NHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospital), Changsha, China.
Xiaoyan XinDepartment of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.ORCID 0000-0003-3462-8835

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potent STING agonists are among the most promising strategies for reversing immunosuppression in "cold" tumors, but

Indexed as

Breast NeoplasmsImmunotherapyMembrane ProteinsNanomedicinePhotochemotherapyPorphyrinsAnimalsCell Line, TumorcGAS-STING Signaling PathwayChlorophyllidesFemaleHumansMiceMice, Inbred BALB CNanoparticlesPhotosensitizing AgentsChlorophyllidesMembrane ProteinsPhotosensitizing AgentsphytochlorinPorphyrinsSting1 protein, mouseSTING Proteincancer immunotherapycarrier-free nanomedicinephotodynamic therapySTING pathway

Identifiers

PMID42370321
PMCPMC13305515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.